Open-Label Crossover Study of Primaquine and Dihydroartemisinin-Piperaquine Pharmacokinetics in Healthy Adult Thai Subjects

Dihydroartemisinin-piperaquine is an artemisinin-based combination treatment (ACT) recommended by the WHO for uncomplicated Plasmodium falciparum malaria, and it is being used increasingly for resistant vivax malaria where combination with primaquine is required for radical cure. The WHO recently re...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Antimicrob Agents Chemother
Auteurs principaux: Hanboonkunupakarn, Borimas, Ashley, Elizabeth A., Jittamala, Podjanee, Tarning, Joel, Pukrittayakamee, Sasithon, Hanpithakpong, Warunee, Chotsiri, Palang, Wattanakul, Thanaporn, Panapipat, Salwaluk, Lee, Sue J., Day, Nicholas P. J., White, Nicholas J.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2014
Sujets:
Clinical Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4249579/
https://ncbi.nlm.nih.gov/pubmed/25267661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03704-14
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires